| Similar Articles |
|---|
 |
Chemistry World
September 26, 2012
Andrew Turley |
Boehringer drops virology R&D German pharma company Boehringer Ingelheim is to close its R&D site in Laval, Canada, in early 2013, with the loss of 170 jobs.   |
Information Today
December 1, 2008 |
Free Resource--Global Library of Women's Medicine The Global Library of Women's Medicine has launched online and is freely available in beta. More than 650 world experts have provided a definitive resource on the latest therapeutic options in women's medicine. |
Chemistry World
February 26, 2014
Ned Stafford |
Roche disputes unethical East German trial claims Clinical trials in the 1980s, performed in former communist East Germany by global pharmaceutical giant Hoffmann-La Roche, adhered to international standards and did not violate East German laws, according to a report issued by the company after a six month internal investigation. |
Chemistry World
July 29, 2015
Phillip Broadwith |
Hikma boosts generics with Roxane buyout UK-headquartered Hikma Pharmaceuticals has agreed to buy Roxane Laboratories -- Boehringer Ingelheim's generic medicines unit -- for a total of $2.65 billion. |
Information Today
December 15, 2015 |
Facebook at Work Nears Official Launch According to Canada's National Post, Facebook is planning to introduce Facebook at Work, a professional version of its social network that is focused on workplace collaboration. |
Chemistry World
November 3, 2014
Phillip Broadwith |
Chinese buyer resurrects US Boehringer plant Chinese company UniTao has agreed to buy a Boehringer Ingelheim manufacturing site in Petersburg, US, which was scheduled to be closed by the end of the year with the loss of 240 jobs. |
Science News
June 24, 2006 |
Visible Proofs This dramatic Web site from the U.S. National Library of Medicine unveils the world of forensic medicine, anthropology, technology, and history. |
Pharmaceutical Executive
April 1, 2007 |
Thoughtleader: Melissa Brown, Center for Value-Based Medicine Here, co-author Melissa Brown discusses her book Evidence-Based to Value-Based Medicine and what's driving the move toward value-based medicine, how it will affect pharma, and why executives should embrace it. |
The Motley Fool
June 21, 2004
Brian Gorman |
Clinical Trials Controversy The American Medical Association wants more transparency in clinical trials, a proposal that may leave drug companies and investors with mixed feelings. |
Chemistry World
November 18, 2009
Sarah Houlton |
A pharmaceutical named desire A new drug being developed by Boehringer Ingelheim could give a boost to the sex drive of women with low libido. |
Information Today
March 4, 2013 |
History of Science, Technology and Medicine Now Available from EBSCO Publishing History of Science, Technology and Medicine reflects the influences of the fields of science, technology, and medicine on society and culture from prehistory to the present and offers outstanding value for interdisciplinary research. |
American Family Physician
September 1, 2006 |
Getting Your Child to Take Medicine What to do if you child won't take his/her medicine. |
American Family Physician
August 1, 2006 |
Antidepressant Discontinuation Syndrome: What You Should Know A patient guide: What is antidepressant discontinuation syndrome?... Which antidepressants can cause this problem?... What can I do if I have antidepressant discontinuation syndrome?... etc. |
BusinessWeek
January 8, 2007
John Carey |
A Little Blue Pill For Women? A German drugmaker has stumbled upon a substance that increases female arousal. |
Science News
June 30, 2007 |
Science Safari: Bad Science A popular blog that looks at science and medicine through a skeptical lens. |
The Motley Fool
January 12, 2011
Brian Orelli |
Drugmaker Math: 4 Halves Beat 2 Wholes Eli Lilly and Boehringer Ingelheim hook up. |
Chemistry World
August 20, 2013
Phillip Broadwith |
Boehringer to close manufacturing plants and cut jobs Boehringer Ingelheim is closing two US manufacturing plants, with a combined loss of 690 jobs. |
Information Today
May 10, 2010 |
Oxford Textbook of Medicine Available Online for the First Time In print, this fifth edition of Oxford Textbook of Medicine is three volumes with just under 6,000 pages, compiled over 5 years by 750 contributors. |
Information Today
February 26, 2015 |
NISO Releases White Paper on the Future of Library Resource Discovery NISO (National Information Standards Organization) published a white paper, "The Future of Library Resource Discovery," which summarizes the current discovery environment. |
Bio-IT World
June 2005
Nancy J. Kelley |
Building Centers of Excellence in Translational Medicine New approaches to drug development that will be more effective in translating research to patient delivery will require the design and construction of new facilities that foster new ways of working among larger, multidisciplinary, teams of scientists and medical professionals in biology, chemistry, physics, mathematics, engineering, computer science, and, of course, information technology. |
Science News
July 10, 2004 |
Medical Advice Affiliated with the International Journal of Medicine, Medicine On-Line taps the knowledge and experience of physicians from around the world, who give impartial reviews of medical issues and also present current research findings. |
Pharmaceutical Executive
June 1, 2006
Sarah Houlton |
Global Report: People Problems A recent clinical trials disaster is causing UK regulators to consider revising its guidelines for Phase I human studies for biologics. However, in many cases, potential solutions present additional problems. |
Search Engine Watch
October 13, 2010
Michael Bonfils |
Top Tips for Search Engine Marketing in Germany, Part 2 Four more SEM/SEO tips to help your efforts in the difficult German market. |
AskMen.com
Richard Stevens |
Participating In Clinical Trials Check out what participating in clinical trials involves and how you can join a study. You may even make some cash in the process. |
The Motley Fool
November 15, 2006
Alyce Lomax |
A Very Complicated Discovery Complexity rules in Discovery Holding's third-quarter results. Investors, take note. |
The Motley Fool
February 28, 2007
Brian Lawler |
Discovery Prepares for Its Fate Discovery Labs announces its quarterly financial results as it prepares for another meeting with the FDA. Investors, take note. |
American Family Physician
December 15, 2006 |
Tips for Using Medicines Wisely A patient guide and suggestions for safe medicine use. |
Bio-IT World
November 12, 2002
Debra Goldfarb |
Disruption --The Real Revolution What is the real promise of the genomic revolution? It is its power to unleash disruptive innovation -- technology that allows a new group of people with different skill sets to do things in a decentralized, less expensive way. |
The Motley Fool
November 15, 2010
Brian Orelli |
A Mega-Blockbuster Showdown Boehringer Ingelheim's Pradaxa was recently approved to treat patients with an erratic heartbeat, and Bayer and Johnson & Johnson have a second compound, Xarelto, that isn't far behind. |
Search Engine Watch
September 3, 2002
Danny Sullivan |
German Search Engine Resources Resources that should be useful to anyone who is a German speaker or interested in German search engines. |
Pharmaceutical Executive
October 1, 2008
RS Kumar |
Evolving Clinical Trials Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in efficiency. |
Bio-IT World
November 2006
Kevin Davies |
Building a Bridge Over Pharma with IT More than 100 enthusiastic delegates bridging the full breadth of the drug development pipeline gathered recently for the second annual Bridging Pharma and IT conference. Here are some highlights. |
The Motley Fool
May 28, 2008
Brian Lawler |
Discovery's Costly Debt Delay Discovery Labs announces a new financing agreement, but it's an expensive arrangement. |
Chemistry World
January 25, 2013
Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
